Pfizer Inc.
PFE
NYSE
$50.66
-$1.22-2.35%
Volume16,458,770
06/28/2022 4:00PM Eastern
Quotes delayed
Recommendation
Prev Close
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 04/03/2022 | 12/31/2021 | 10/03/2021 | 07/04/2021 | 04/04/2021 | |
|---|---|---|---|---|---|
| Revenue | 25.66B | 23.64B | 24.09B | 18.98B | 14.52B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.66B | 23.64B | 24.09B | 18.98B | 14.52B |
| Cost of Revenue | 9.95B | 9.57B | 9.93B | 6.99B | 4.12B |
| Gross Profit | 15.71B | 14.07B | 14.16B | 11.99B | 10.39B |
| SG&A Expenses | 2.22B | 2.83B | 1.60B | 2.55B | 2.38B |
| Depreciation & Amortization | 835.00M | 916.00M | 981.00M | 931.00M | 858.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.31B | 16.81B | 15.25B | 12.75B | 9.35B |
| Operating Income | 10.35B | 6.83B | 8.84B | 6.23B | 5.16B |
| Income Before Tax | 9.05B | 4.18B | 7.84B | 6.61B | 5.69B |
| Income Tax Expenses | 1.17B | 334.00M | -331.00M | 1.04B | 808.00M |
| Earnings from Continuing Operations | 7.88B | 3.85B | 8.17B | 5.57B | 4.89B |
| Earnings from Discontinued Operations | -9.00M | -458.00M | -9.00M | 24.00M | 1.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -6.00M | 2.00M | -12.00M | -26.00M | -9.00M |
| Net Income | 7.86B | 3.39B | 8.15B | 5.56B | 4.88B |
| EBIT | 10.35B | 6.83B | 8.84B | 6.23B | 5.16B |
| EBITDA | 11.53B | 8.11B | 10.17B | 7.51B | 6.36B |
| EPS Basic | 1.40 | 0.60 | 1.45 | 0.99 | 0.87 |
| Normalized Basic EPS | 1.17 | 0.76 | 1.01 | 0.72 | 0.62 |
| EPS Diluted | 1.37 | 0.59 | 1.42 | 0.98 | 0.86 |
| Normalized Diluted EPS | 1.14 | 0.74 | 0.98 | 0.71 | 0.61 |
| Average Basic Shares Outstanding | 5.62B | 5.62B | 5.61B | 5.60B | 5.58B |
| Average Diluted Shares Outstanding | 5.76B | 5.77B | 5.73B | 5.68B | 5.66B |
| Dividend Per Share | 0.40 | 0.39 | 0.39 | 0.39 | 0.39 |
| Payout Ratio | 28.60% | 64.52% | 26.82% | 39.24% | 44.54% |
